Sua seleção (0)
Detalhe da pesquisa
1.
Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche.
Nature;
514(7520): 92-97, 2014 Oct 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-25231870
2.
Association analysis identifies 65 new breast cancer risk loci.
Nature;
551(7678): 92-94, 2017 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29059683
3.
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.
Am J Hum Genet;
104(1): 21-34, 2019 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30554720
4.
Cancer: more genetic BRCA testing for men.
Nature;
573(7774): 346, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31530924
5.
The spectrum of BRCA1 and BRCA2 pathogenic sequence variants in Middle Eastern, North African, and South European countries.
Hum Mutat;
40(11): e1-e23, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31209999
6.
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification.
Hum Mutat;
40(9): 1557-1578, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31131967
7.
Insight into genetic susceptibility to male breast cancer by multigene panel testing: Results from a multicenter study in Italy.
Int J Cancer;
145(2): 390-400, 2019 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30613976
8.
Genome-wide association study of germline variants and breast cancer-specific mortality.
Br J Cancer;
120(6): 647-657, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30787463
9.
Prognostic impact of genetic variants of CYP19A1 and UGT2B17 in a randomized trial for endocrine-responsive postmenopausal breast cancer.
Pharmacogenomics J;
2019 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30967597
10.
Hereditary lobular breast cancer with an emphasis on E-cadherin genetic defect.
J Med Genet;
55(7): 431-441, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29929997
11.
BRCA1 and BRCA2 5' noncoding region variants identified in breast cancer patients alter promoter activity and protein binding.
Hum Mutat;
39(12): 2025-2039, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30204945
12.
The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity.
Hum Mutat;
39(5): 729-741, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29460995
13.
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations.
Hum Mutat;
39(5): 593-620, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29446198
14.
Whole-exome sequencing and targeted gene sequencing provide insights into the role of PALB2 as a male breast cancer susceptibility gene.
Cancer;
123(2): 210-218, 2017 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27648926
15.
Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial.
Lancet;
387(10021): 866-73, 2016 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-26686313
16.
Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3.
Breast Cancer Res Treat;
161(1): 117-134, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27796716
17.
Triple-Negative versus Non-Triple-Negative Breast Cancers in High-Risk Women: Phenotype Features and Survival from the HIBCRIT-1 MRI-Including Screening Study.
Clin Cancer Res;
22(4): 895-904, 2016 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26503945
18.
Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial.
Breast Cancer Res;
18(1): 110, 2016 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27825388
19.
Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus.
Breast Cancer Res;
18(1): 64, 2016 06 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-27459855
20.
Benefit of low-dose tamoxifen in a large observational cohort of high risk ER positive breast DCIS.
Int J Cancer;
139(9): 2127-34, 2016 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27381855